Voglax MG1
OTC In Stock
Voglax MG1
Voglax MG1 is a tablet formulation from Cardivista for healthcare-led B2B supply. It is suitable for clinics, pharmacies, hospitals, distributors, and healthcare businesses looking for clear product information.
Brand
Cardivista
Composition
Metformin Hydrochloride (SR), Glimepiride & Voglibose Tablets
Manufacturer
Cardivista Pharma Pvt. Ltd.
Pack Size
10 x 15 Tablets
Form
Tablet
Storage
Store below 30°C, dry place
This prescription-based tablet formulation, as detailed in image_0b3c6a.png, contains the active ingredients Metformin Hydrochloride (SR), Glimepiride & Voglibose Tablets. Available in a 10 x 15 tablet pack size, it is professionally intended for prescription-based diabetes management as advised by a doctor. The product is highly suitable for anti-diabetic product listings targeted toward clinics, pharmacies, hospitals, and commercial distributors. Patients must use this medication only as directed by a registered healthcare professional, taking it precisely at the prescribed time and dose without stopping, repeating, or altering the dosage without medical advice. Finally, it must be administered strictly under medical supervision with blood sugar monitored as advised, ensuring it is kept completely out of reach of children and that the label, leaflet, batch number, and expiry date are verified before dispensing.